Liling Zhang
Clinical trials sponsored by Liling Zhang, explained in plain language.
-
New drug cocktail shows promise against rare blood cancer
Disease control Recruiting nowThis study tests whether combining two drugs, duvelisib and chidamide, can safely control peripheral T-cell lymphoma in people who are newly diagnosed. About 36 adults aged 18 to 70 will receive the combination and be monitored for side effects and how well the cancer responds. T…
Phase: PHASE2 • Sponsor: Liling Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Radiation boosts new drug against tough lymphoma?
Disease control Recruiting nowThis phase 2 trial tests whether adding a short course of radiation to the drug glofitamab can help people with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who have large tumors. About 40 adults in China will receive glofitamab plus radiation. The main goal is to…
Phase: PHASE2 • Sponsor: Liling Zhang • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC